From Wikipedia, the free encyclopedia
  (Redirected from Micro RNA)
Jump to: navigation, search
Diagram of miRNA action with mRNA
The stem-loop secondary structure of a pre-microRNA from Brassica oleracea.

A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals, and some viruses, which functions in post-transcriptional regulation of gene expression.[1] Encoded by eukaryotic nuclear DNA in plants and animals and by viral DNA in certain viruses whose genome is based on DNA, miRNAs function via base-pairing with complementary sequences within mRNA molecules.[2] As a result, these mRNA molecules are silenced by one or more of the following processes: 1) cleavage of the mRNA strand into two pieces, 2) destabilization of the mRNA, through shortening of its poly(A) tail, and 3) less efficient translation of the mRNA into proteins by ribosomes.[2][3] The human genome may encode over 1000 miRNAs,[4][5] which are abundant in many mammalian cell types[6][7] and appear to target about 60% of the genes of humans and other mammals.[8][9]

miRNAs are well conserved in both plants and animals, and are thought to be a vital and evolutionarily ancient component of genetic regulation.[10][11][12][13] While core components of the microRNA pathway are conserved between plants and animals, miRNA repertoires in the two kingdoms appear to have emerged independently with different primary modes of action.[14][15] Plant miRNAs usually have near-perfect pairing with their mRNA targets, which induces gene repression through cleavage of the target transcripts.[16] In contrast, animal miRNAs are able to recognize their target mRNAs by using as little as 6–8 nucleotides (the seed region) at the 5' end of the miRNA,[8][17] which is not enough pairing to induce cleavage of the target mRNAs.[2] Combinatorial regulation is a feature of miRNA regulation in animals.[2][18] A given miRNA may have hundreds different mRNA targets, and a given target might be regulated by multiple miRNAs.[9][19]

The first miRNA was discovered in the early 1990s.[20] However, miRNAs were not recognized as a distinct class of biological regulators until the early 2000s.[21][22][23][24][25] Since then, miRNA research has revealed different sets of miRNAs expressed in different cell types and tissues[7] and has revealed multiple roles for miRNAs in plant and animal development and in many other biological processes.[26][27][28][29][30][31][32] Aberrant expression of miRNAs has been implicated in numerous disease states, and miRNA-based therapies are under investigation.[33][34][35][36]

Estimates of the average number of unique messenger RNAs that are targets for repression by a typical microRNA vary, depending on the method used to make the estimate.[37] While a 2004 estimate was that the mean number of target mRNAs for a typical microRNA is only 7,[38] later estimates were higher. Krek et al.[39] found that vertebrate microRNAs target, on average, roughly 200 transcripts each. Selbach et al.[40] and Baek et al.[41] indicated that a single miRNA may repress the production of hundreds of proteins, but that this repression often is relatively mild (less than 2-fold).


MicroRNAs were discovered in 1993 by Victor Ambros, Rosalind Lee and Rhonda Feinbaum during a study of the gene lin-14 in C. elegans development.[20] They found that LIN-14 protein abundance was regulated by a short RNA product encoded by the lin-4 gene. A 61-nucleotide precursor from the lin-4 gene matured to a 22-nucleotide RNA that contained sequences partially complementary to multiple sequences in the 3' UTR of the lin-14 mRNA. This complementarity was both necessary and sufficient to inhibit the translation of the lin-14 mRNA into the LIN-14 protein. Retrospectively, the lin-4 small RNA was the first microRNA to be identified, though at the time, it was thought to be a nematode idiosyncrasy. Only in 2000 was a second RNA characterized: let-7, which repressed lin-41, lin-14, lin-28, lin-42, and daf-12 expression during developmental stage transitions in C. elegans. let-7 was soon found to be conserved in many species,[21][22] indicating the existence of a wider phenomenon.


Under a standard nomenclature system, names are assigned to experimentally confirmed miRNAs before publication of their discovery.[42][43] The prefix "miR" is followed by a dash and a number, the latter often indicating order of naming. For example, miR-124 was named and likely discovered prior to miR-456. A capitalized "miR-" refers to the mature form of the miRNA, while the uncapitalized "mir-" refers to the pre-miRNA and the pri-miRNA, and "MIR" refers to the gene that encodes them.[44] miRNAs with nearly identical sequences except for one or two nucleotides are annotated with an additional lower case letter. For example, miR-124a is closely related to miR-124b. Pre-miRNAs, pri-miRNAs and genes that lead to 100% identical mature miRNAs but that are located at different places in the genome are indicated with an additional dash-number suffix. For example, the pre-miRNAs hsa-mir-194-1 and hsa-mir-194-2 lead to an identical mature miRNA (hsa-miR-194) but are from genes located in different regions of the genome. Species of origin is designated with a three-letter prefix, e.g., hsa-miR-124 is a human (Homo sapiens) miRNA and oar-miR-124 is a sheep (Ovis aries) miRNA. Other common prefixes include 'v' for viral (miRNA encoded by a viral genome) and 'd' for Drosophila miRNA (a fruit fly commonly studied in genetic research). When two mature microRNAs originate from opposite arms of the same pre-miRNA and are found in roughly similar amounts, they are denoted with a -3p or -5p suffix. (In the past, this distinction was also made with 's' (sense) and 'as' (antisense)). However, the mature microRNA found from one arm of the hairpin is usually much more abundant than that found from the other arm,[45] in which case, an asterisk following the name indicates the mature species found at low levels from the opposite arm of a hairpin. For example, miR-124 and miR-124* share a pre-miRNA hairpin, but much more miR-124 is found in the cell.



MicroRNAs are produced from either their own genes or from introns. A video of this process can be found here.

The majority of the characterized miRNA genes are intergenic or oriented antisense to neighboring genes and are therefore suspected to be transcribed as independent units.[24][24][46][23][25] However, in some cases a microRNA gene is transcribed together with its host gene; this provides a means for coupled regulation of miRNA and protein-coding gene.[47] As much as 40% of miRNA genes may lie in the introns of protein and non-protein coding genes or even in exons of long nonprotein-coding transcripts.[48] These are usually, though not exclusively, found in a sense orientation,[49][50] and thus usually are regulated together with their host genes.[48][51][52] Other miRNA genes showing a common promoter include the 42-48% of all miRNAs originating from polycistronic units containing multiple discrete loops from which mature miRNAs are processed,[46][53] although this does not necessarily mean the mature miRNAs of a family will be homologous in structure and function. The promoters mentioned have been shown to have some similarities in their motifs to promoters of other genes transcribed by RNA polymerase II such as protein coding genes.[46][54] The DNA template is not the final word on mature miRNA production: 6% of human miRNAs show RNA editing (IsomiRs), the site-specific modification of RNA sequences to yield products different from those encoded by their DNA. This increases the diversity and scope of miRNA action beyond that implicated from the genome alone.


miRNA genes are usually transcribed by RNA polymerase II (Pol II).[46][54] The polymerase often binds to a promoter found near the DNA sequence encoding what will become the hairpin loop of the pre-miRNA. The resulting transcript is capped with a specially modified nucleotide at the 5’ end, polyadenylated with multiple adenosines (a poly(A) tail),[46][49] and spliced. Animal miRNAs are initially transcribed as part of one arm of an ∼80 nucleotide RNA stem-loop that in turn forms part of a several hundred nucleotides long miRNA precursor termed a primary miRNA (pri-miRNA)s.[46][49] When a stem-loop precursor is found in the 3' UTR, a transcript may serve as a pri-miRNA and a mRNA.[49] RNA polymerase III (Pol III) transcribes some miRNAs, especially those with upstream Alu sequences, transfer RNAs (tRNAs), and mammalian wide interspersed repeat (MWIR) promoter units.[55]

Nuclear processing[edit]

A single pri-miRNA may contain from one to six miRNA precursors. These hairpin loop structures are composed of about 70 nucleotides each. Each hairpin is flanked by sequences necessary for efficient processing. The double-stranded RNA structure of the hairpins in a pri-miRNA is recognized by a nuclear protein known as DiGeorge Syndrome Critical Region 8 (DGCR8 or "Pasha" in invertebrates), named for its association with DiGeorge Syndrome. DGCR8 associates with the enzyme Drosha, a protein that cuts RNA, to form the "Microprocessor" complex.[56] In this complex, DGCR8 orients the catalytic RNase III domain of Drosha to liberate hairpins from pri-miRNAs by cleaving RNA about eleven nucleotides from the hairpin base (two helical RNA turns into the stem). The product resulting has a two-nucleotide overhang at its 3’ end; it has 3' hydroxyl and 5' phosphate groups. It is often termed as a pre-miRNA (precursor-miRNA).

Pre-miRNAs that are spliced directly out of introns, bypassing the Microprocessor complex, are known as "Mirtrons." Originally thought to exist only in Drosophila and C. elegans, mirtrons have now been found in mammals.[57]

Perhaps as many as 16% of pre-miRNAs may be altered through nuclear RNA editing.[58][59][60] Most commonly, enzymes known as adenosine deaminases acting on RNA (ADARs) catalyze adenosine to inosine (A to I) transitions. RNA editing can halt nuclear processing (for example, of pri-miR-142, leading to degradation by the ribonuclease Tudor-SN) and alter downstream processes including cytoplasmic miRNA processing and target specificity (e.g., by changing the seed region of miR-376 in the central nervous system).[58]

Nuclear export[edit]

Pre-miRNA hairpins are exported out of the nucleus in a process involving the nucleocytoplasmic shuttler Exportin-5. This protein, a member of the karyopherin family, recognizes a two-nucleotide overhang left by the RNase III enzyme Drosha at the 3' end of the pre-miRNA hairpin. Exportin-5-mediated transport to the cytoplasm is energy-dependent, using GTP bound to the Ran protein.[61]

Cytoplasmic processing[edit]

In the cytoplasm, the pre-miRNA hairpin is cleaved by the RNase III enzyme Dicer.[62] This endoribonuclease interacts with the 3' end of the hairpin and cuts away the loop joining the 3' and 5' arms, yielding an imperfect miRNA:miRNA* duplex about 22 nucleotides in length.[62] Overall hairpin length and loop size influence the efficiency of Dicer processing, and the imperfect nature of the miRNA:miRNA* pairing also affects cleavage.[62][63] Although either strand of the duplex may potentially act as a functional miRNA, only one strand is usually incorporated into the RNA-induced silencing complex (RISC) where the miRNA and its mRNA target interact.

Biogenesis in plants[edit]

miRNA biogenesis in plants differs from animal biogenesis mainly in the steps of nuclear processing and export. Instead of being cleaved by two different enzymes, once inside and once outside the nucleus, both cleavages of the plant miRNA is performed by a Dicer homolog, called Dicer-like1 (DL1). DL1 is only expressed in the nucleus of plant cells, which indicates that both reactions take place inside the nucleus. Before plant miRNA:miRNA* duplexes are transported out of the nucleus, its 3' overhangs are methylated by a RNA methyltransferaseprotein called Hua-Enhancer1 (HEN1). The duplex is then transported out of the nucleus to the cytoplasm by a protein called Hasty (HST), an Exportin 5 homolog, where they disassemble and the mature miRNA is incorporated into the RISC.[64]

The RNA-induced silencing complex[edit]

The mature miRNA is part of an active RNA-induced silencing complex (RISC) containing Dicer and many associated proteins.[65] RISC is also known as a microRNA ribonucleoprotein complex (miRNP);[66] RISC with incorporated miRNA is sometimes referred to as "miRISC."

Dicer processing of the pre-miRNA is thought to be coupled with unwinding of the duplex. Generally, only one strand is incorporated into the miRISC, selected on the basis of its thermodynamic instability and weaker base-pairing relative to the other strand.[67][68][69] The position of the stem-loop may also influence strand choice.[70] The other strand, called the passenger strand due to its lower levels in the steady state, is denoted with an asterisk (*) and is normally degraded. In some cases, both strands of the duplex are viable and become functional miRNA that target different mRNA populations.[71]

Members of the Argonaute (Ago) protein family are central to RISC function. Argonautes are needed for miRNA-induced silencing and contain two conserved RNA binding domains: a PAZ domain that can bind the single stranded 3’ end of the mature miRNA and a PIWI domain that structurally resembles ribonuclease-H and functions to interact with the 5’ end of the guide strand. They bind the mature miRNA and orient it for interaction with a target mRNA. Some argonautes, for example human Ago2, cleave target transcripts directly; argonautes may also recruit additional proteins to achieve translational repression.[72] The human genome encodes eight argonaute proteins divided by sequence similarities into two families: AGO (with four members present in all mammalian cells and called E1F2C/hAgo in humans), and PIWI (found in the germ line and hematopoietic stem cells).[66][72]

Additional RISC components include TRBP [human immunodeficiency virus (HIV) transactivating response RNA (TAR) binding protein],[73] PACT (protein activator of the interferon induced protein kinase (PACT), the SMN complex, fragile X mental retardation protein (FMRP), Tudor staphylococcal nuclease-domain-containing protein (Tudor-SN), the putative DNA helicase MOV10, and the RNA recognition motif containing protein TNRC6B.[61][74][75]

Mode of silencing[edit]

Gene silencing may occur either via mRNA degradation or preventing mRNA from being translated. For example, miR16 contains a sequence complementary to the AU-rich element found in the 3'UTR of many unstable mRNAs, such as TNF alpha or GM-CSF (ref Jing, Q., et al. Cell 2005 pmid = 15766526). It has been demonstrated that if there is complete complementation between the miRNA and target mRNA sequence, Ago2 can cleave the mRNA and lead to direct mRNA degradation. Yet, if there isn't complete complementation the silencing is achieved by preventing translation.[76]

miRNA turnover[edit]

Turnover of mature miRNA is needed for rapid changes in miRNA expression profiles. During miRNA maturation in the cytoplasm, uptake by the Argonaute protein is thought to stabilize the guide strand, while the opposite (* or "passenger") strand is preferentially destroyed. In what has been called a "Use it or lose it" strategy, Argonaute may preferentially retain miRNAs with many targets over miRNAs with few or no targets, leading to degradation of the non-targeting molecules.[77]

Decay of mature miRNAs in Caenorhabditis elegans is mediated by the 5´-to-3´ exoribonuclease XRN2, also known as Rat1p.[78] In plants, SDN (small RNA degrading nuclease) family members degrade miRNAs in the opposite (3'-to-5') direction. Similar enzymes are encoded in animal genomes, but their roles have not yet been described.[77]

Several miRNA modifications affect miRNA stability. As indicated by work in the model organism Arabidopsis thaliana (thale cress), mature plant miRNAs appear to be stabilized by the addition of methyl moieties at the 3' end. The 2'-O-conjugated methyl groups block the addition of uracil (U) residues by uridyltransferase enzymes, a modification that may be associated with miRNA degradation. However, uridylation may also protect some miRNAs; the consequences of this modification are incompletely understood. Uridylation of some animal miRNAs has also been reported. Both plant and animal miRNAs may be altered by addition of adenine (A) residues to the 3' end of the miRNA. An extra A added to the end of mammalian miR-122, a liver-enriched miRNA important in Hepatitis C, stabilizes the molecule, and plant miRNAs ending with an adenine residue have slower decay rates.[77]

Cellular functions[edit]

Interaction of microRNA with protein translation process. Several (from nine documented) mechanisms of translation repression are shown: M1) on the initiation process, preventing assembling of the initiation complex or recruiting the 40S ribosomal subunit; M2) on the ribosome assembly; M3) on the translation process; M7, M8) on the degradation of mRNA. There exist other mechanisms of microRNA action on protein translation (transcriptional, transport to P-bodies, ribosome drop-off, co-translational protein degradation and others) that are not visualized here.[79] Here, 40S and 60S are light and heavy components of the ribosome, 80S is the assembled ribosome bound to mRNA, eIF4F is an translation initiation factor, PABC1 is the Poly-A binding protein, and "cap" is the mRNA cap structure needed for mRNA circularization (which can be the normal m7G-cap or artificial modified A-cap). The initiation of mRNA can proceed in a cap-independent manner, through recruiting 40S to IRES (Internal Ribosome Entry Site) located in 5’UTR region. The actual work of RNA silencing is performed by RISC (RNA-induced silencing complex) in which the main catalytic subunit is one of the Argonaute proteins (AGO), and miRNA serves as a template for recognizing specific mRNA sequences.

The function of miRNAs appears to be in gene regulation. For that purpose, a miRNA is complementary to a part of one or more messenger RNAs (mRNAs). Animal miRNAs are usually complementary to a site in the 3' UTR whereas plant miRNAs are usually complementary to coding regions of mRNAs.[80] Perfect or near perfect base pairing with the target RNA promotes cleavage of the RNA.[81] This is the primary mode of plant miRNAs.[82] In animals miRNAs more often have only partly the right sequence of nucleotides to bond with the target mRNA. The match-ups are imperfect. For partially complementary microRNAs to recognise their targets, nucleotides 2–7 of the miRNA (its 'seed region'[8][17]) still have to be perfectly complementary.[83] Animal miRNAs inhibit protein translation of the target mRNA[84] (this exists in plants as well but is less common).[82] MicroRNAs that are partially complementary to a target can also speed up deadenylation, causing mRNAs to be degraded sooner.[85] While degradation of miRNA-targeted mRNA is well documented, whether or not translational repression is accomplished through mRNA degradation, translational inhibition, or a combination of the two is hotly debated. Recent work on miR-430 in zebrafish, as well as on bantam-miRNA and miR-9 in Drosophila cultured cells, shows that translational repression is caused by the disruption of translation initiation, independent of mRNA deadenylation.[86][87]

miRNAs occasionally also cause histone modification and DNA methylation of promoter sites, which affects the expression of target genes.[88][89]

Nine mechanisms of miRNA action are described and assembled in a unified mathematical model:[79]

  1. Cap-40S initiation inhibition;
  2. 60S Ribosomal unit joining inhibition;
  3. Elongation inhibition;
  4. Ribosome drop-off (premature termination);
  5. Co-translational nascent protein degradation;
  6. Sequestration in P-bodies;
  7. mRNA Decay (destabilisation);
  8. mRNA Cleavage;
  9. Transcriptional inhibition through microRNA-mediated chromatin reorganization following by gene silencing.

It is often impossible to discern these mechanisms using the experimental data about stationary reaction rates. Nevertheless, they are differentiated in dynamics and have different kinetic signatures.[79]

Unlike plant microRNAs, the animal microRNAs target a diverse set of genes.[17] However, genes involved in functions common to all cells, such as gene expression, have relatively fewer microRNA target sites and seem to be under selection to avoid targeting by microRNAs.[90]

dsRNA can also activate gene expression, a mechanism that has been termed "small RNA-induced gene activation" or RNAa. dsRNAs targeting gene promoters can induce potent transcriptional activation of associated genes. This was demonstrated in human cells using synthetic dsRNAs termed small activating RNAs (saRNAs),[91] but has also been demonstrated for endogenous microRNA.[92]

Interactions between microRNAs and complementary sequences on genes and even pseudogenes that share sequence homology are thought to be a back channel of communication regulating expression levels between paralogous genes. Given the name "competing endogenous RNAs" (ceRNAs), these microRNAs bind to "microRNA response elements" on genes and pseudogenes and may provide another explanation for the persistence of non-coding DNA.[93]


MicroRNAs are significant phylogenetic markers because of their astonishingly low rate of evolution.[94] MicroRNAs origin as a regulatory mechanism developed from previous RNAi machinery which was initially used as a defense against exogenous genetic material such as viruses.[95] Their origin may have permitted the development of morphological innovation, and by making gene expression more specific and 'fine-tunable', permitted the genesis of complex organs[96] and perhaps, ultimately, complex life.[97] Indeed, rapid bursts of morphological innovation are generally associated with a high rate of microRNA accumulation.[94][96]

New microRNAs are created in multiple different ways. Novel microRNAs can originate from the random formation of hairpins in "non-coding" sections of DNA (i.e. introns or intergene regions), but also by the duplication and modification of existing microRNAs.[98] MicroRNAs can also form from inverted duplications of protein-coding sequences, which allows for the creation of a foldback hairpin structure.[99] The rate of evolution (i.e. nucleotide substitution) in recently originated microRNAs is comparable to that elsewhere in the non-coding DNA, implying evolution by neutral drift; however, older microRNAs have a much lower rate of change (often less than one substitution per hundred million years),[97] suggesting that once a microRNA gains a function it undergoes extreme purifying selection.[98] Additionally, different regions within an miRNA gene seem to be under different evolutionary pressures, where regions that are vital for processing and function have much higher levels of conservation.[100] At this point, a microRNA is rarely lost from an animal's genome,[97] although microRNAs that are more recently derived (and thus presumably non-functional) are frequently lost.[98] In Arabidopsis thaliana, the net flux of miRNA genes has been predicted to be between 1.2 and 3.3 genes per million years.[101] This makes them a valuable phylogenetic marker, and they are being looked upon as a possible solution to such outstanding phylogenetic problems as the relationships of arthropods.[102]

MicroRNAs feature in the genomes of most eukaryotic organisms, from the brown algae[103] to the animals. However, the difference in how these microRNAs function and the way they are processed suggests that microRNAs arose independently in plants and animals.[104] Focusing on the animals, the genome of Mnemiopsis leidyi [105] appears to lack recognizable microRNAs, as well as the nuclear proteins Drosha and Pasha, which are critical to canonical microRNA biogenesis. It is the only animal thus far reported to be missing Pasha. MicroRNAs play a vital role in the regulation of gene expression in all non-ctenophore animals investigated thus far except for Trichoplax adhaerens, the only known member of the phylum Placozoa.[106]

Across all species, in excess of 5000 had been identified by March 2010.[107] Whilst short RNA sequences (50 – hundreds of base pairs) of a broadly comparable function occur in bacteria, bacteria lack true microRNAs.[108]

Experimental detection and manipulation of miRNA[edit]

While researchers have focused on the study of miRNA expression in physiological and pathological processes, various technical variables related to microRNA isolation have emerged. The stability of the stored miRNA samples has often been questioned.[109] MicroRNAs are degraded much more easily than mRNAs, partly due to their length, but also because of the ubiquitously present RNases. This makes it necessary to cool samples on ice and use RNase-free equipment whenever working with microRNAs.[110]

MicroRNA expression can be quantified in a two-step polymerase chain reaction process of modified RT-PCR followed by quantitative PCR. Variations of this method achieve absolute or relative quantification.[111] miRNAs can also be hybridized to microarrays, slides or chips with probes to hundreds or thousands of miRNA targets, so that relative levels of miRNAs can be determined in different samples.[112] MicroRNAs can be both discovered and profiled by high-throughput sequencing methods (MicroRNA Sequencing).[113] The activity of an miRNA can be experimentally inhibited using a locked nucleic acid (LNA) oligo, a Morpholino oligo[114][115] or a 2'-O-methyl RNA oligo.[116] Additionally, a specific miRNA can be silenced by a complementary antagomir. MicroRNA maturation can be inhibited at several points by steric-blocking oligos.[117] The miRNA target site of an mRNA transcript can also be blocked by a steric-blocking oligo.[118] For the “in situ” detection of miRNA, LNA[119] or Morpholino[120] probes can be used. The locked conformation of LNA results in enhanced hybridization properties and increases sensitivity and selectivity, making it ideal for detection of short miRNA.[121]

High-throughput quantification of miRNAs is often difficult and prone to errors, for the larger variance (compared to mRNAs) that comes with the methodological problems. mRNA-expression is therefore often analyzed as well to check for miRNA-effects in their levels (e. g. in [122][123]). To pair mRNA- and miRNA-data, databases can be used which predict miRNA-targets based on their base sequence.[124][125] While this is usually done after miRNAs of interest have been detected (e. g. because of high expression levels), ideas for analysis tools that integrate mRNA- and miRNA-expression information have been proposed.[126][127]

miRNA and disease[edit]

Just as miRNA is involved in the normal functioning of eukaryotic cells, so has dysregulation of miRNA been associated with disease.[128] A manually curated, publicly available database, miR2Disease, documents known relationships between miRNA dysregulation and human disease.[129]

miRNA and inherited diseases[edit]

A mutation in the seed region of miR-96 causes hereditary progressive hearing loss.[130] A mutation in the seed region of miR-184 causes hereditary keratoconus with anterior polar cataract.[131] Deletion of the miR-17~92 cluster causes skeletal and growth defects.[132]

miRNA and cancer[edit]

Role of miRNA in a cancer cell

The first human disease known to be associated with miRNA deregulation was chronic lymphocytic leukemia.[128] Many miRNAs have subsequently been found to have links with various types of cancer[128][133][134] and accordingly are sometimes referred to as "oncomirs". MicroRNA-21 is involved in several cancer-types such as glioblastoma and astrocytoma was one of the first microRNAs to be identified as an oncomir.[135]

A study of mice altered to produce excess c-Myc — a protein with mutated forms implicated in several cancers — shows that miRNA has an effect on the development of cancer. Mice that were engineered to produce a surplus of types of miRNA found in lymphoma cells developed the disease within 50 days and died two weeks later. In contrast, mice without the surplus miRNA lived over 100 days.[133] Leukemia can be caused by the insertion of a viral genome next to the 17-92 array of microRNAs leading to increased expression of this microRNA.[136]

Another study found that two types of miRNA inhibit the E2F1 protein, which regulates cell proliferation. miRNA appears to bind to messenger RNA before it can be translated to proteins that switch genes on and off.[137]

By measuring activity among 217 genes encoding miRNA, patterns of gene activity that can distinguish types of cancers can be discerned. miRNA signatures may enable classification of cancer. This will allow doctors to determine the original tissue type which spawned a cancer and to be able to target a treatment course based on the original tissue type.[138] miRNA profiling has already been able to determine whether patients with chronic lymphocytic leukemia had slow growing or aggressive forms of the cancer.[134]

Transgenic mice that over-express or lack specific miRNAs have provided insight into the role of small RNAs in various malignancies.[139] Much work has also been done on the role of microRNAs in establishing and maintaining cancer stem cells that are especially resistant to chemotherapy and often responsible for relapse.[140]

A novel miRNA-profiling based screening assay for the detection of early-stage colorectal cancer has been developed and is currently in clinical trials. Early results showed that blood plasma samples collected from patients with early, resectable (Stage II) colorectal cancer could be distinguished from those of sex-and age-matched healthy volunteers. Sufficient selectivity and specificity could be achieved using small (less than 1 mL) samples of blood. The test has potential to be a cost-effective, non-invasive way to identify at-risk patients who should undergo colonoscopy.[141][142]

Another role for miRNA in cancers is to use their expression level as a prognostic. For example, one study on NSCLC samples found that low miR-324a levels could serve as a prognostic indicator of poor survival.[143] Either high miR-185 or low miR-133b levels may correlate with metastasis and poor survival in colorectal cancer.[144] Hepatocellular carcinoma cell proliferation may arise from miR-21 interaction with MAP2K3, a tumor repressor gene.[145] Optimal treatment for cancer involves accurately identifying patients for risk-stratified therapy. Those with a rapid response to initial treatment may benefit from truncated treatment regimens, thus the need for more accurate measures of disease response. Cell-free miRNA are highly stable in blood, are overexpressed in cancer, and are quantifiable within the diagnostic laboratory. In classical Hodgkin lymphoma, plasma miR-21, miR-494, and miR-1973 are promising disease response biomarkers.[146] Circulating miRNAs have the potential to greatly assist clinical decision making and aid interpretation of positron emission tomography combined with computerized tomography. A further advantage is they can also be performed at each consultation to assess disease response and detection of early relapse.

Recent studies have miR-205 targeted for inhibiting the metastatic nature of breast cancer.[147] Five members of the microRNA-200 family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) are down regulated in tumour progression of breast cancer.[148]

miRNA, DNA repair and cancer[edit]

DNA damage is considered to be the primary underlying cause of cancer.[149] If DNA repair is deficient, damage tends to accumulate in DNA. Such DNA damage can cause mutational errors during DNA replication due to error-prone translesion synthesis. Accumulated DNA damage can also cause epigenetic alterations due to errors during DNA repair.[150][151] Such mutations and epigenetic alterations can give rise to cancer (see malignant neoplasms).

Germ line mutations in DNA repair genes cause only 2–5% of colon cancer cases.[152] However, altered expression of microRNAs, causing DNA repair deficiencies, are frequently associated with cancers and may be an important causal factor for these cancers.

Among 68 sporadic colon cancers with reduced expression of the DNA mismatch repair protein MLH1, most were found to be deficient due to epigenetic methylation of the CpG island of the MLH1 gene.[153] However, up to 15% of the MLH1-deficiencies in sporadic colon cancers appeared to be due to over-expression of the microRNA miR-155, which represses MLH1 expression.[154]

In 29–66%[155][156] of glioblastomas, DNA repair is deficient due to epigenetic methylation of the MGMT gene, which reduces protein expression of MGMT. However, for 28% of glioblastomas, the MGMT protein is deficient but the MGMT promoter is not methylated.[155] In the glioblastomas without methylated MGMT promoters, the level of microRNA miR-181d is inversely correlated with protein expression of MGMT and the direct target of miR-181d is the MGMT mRNA 3’UTR (the three prime untranslated region of MGMT mRNA).[155] Thus, in 28% of glioblastomas, increased expression of miR-181d and reduced expression of DNA repair enzyme MGMT may be a causal factor.

HMGA proteins (HMGA1a, HMGA1b and HMGA2) are implicated in cancer, and expression of these proteins is regulated by microRNAs. HMGA expression is almost undetectable in differentiated adult tissues but is elevated in many cancers. HGMA proteins are polypeptides of ~100 amino acid residues characterized by a modular sequence organization. These proteins have three highly positively-charged regions, termed AT hooks, that bind the minor groove of AT-rich DNA stretches in specific regions of DNA. Human neoplasias, including thyroid, prostatic, cervical, colorectal, pancreatic and ovarian carcinoma, show a strong increase of HMGA1a and HMGA1b proteins.[157] Transgenic mice with HMGA1 targeted to lymphoid cells develop aggressive lymphoma, showing that high HMGA1 expression is not only associated with cancers, but that the HMGA1 gene can act as an oncogene to cause cancer.[158] Baldassarre et al.,[159] showed that HMGA1 protein binds to the promoter region of DNA repair gene BRCA1 and inhibits BRCA1 promoter activity. They also showed that while only 11% of breast tumors had hypermethylation of the BRCA1 gene, 82% of aggressive breast cancers have low BRCA1 protein expression, and most of these reductions were due to chromatin remodeling by high levels of HMGA1 protein.

HMGA2 protein specifically targets the promoter of ERCC1, thus reducing expression of this DNA repair gene.[160] ERCC1 protein expression was deficient in 100% of 47 evaluated colon cancers (though the extent to which HGMA2 was involved is not known).[161] Palmieri et al.[162] showed that, in normal tissues, HGMA1 and HMGA2 genes are targeted (and thus strongly reduced in expression) by miR-15, miR-16, miR-26a, miR-196a2 and Let-7a. However, each of these HMGA-targeting miRNAs are drastically reduced in almost all human pituitary adenomas studied, when compared with the normal pituitary gland. Consistent with the down-regulation of these HMGA-targeting miRNAs, an increase in the HMGA1 and HMGA2-specific mRNAs was observed. Three of these microRNAs (miR-16, miR-196a and Let-7a)[163][164] have methylated promoters and therefore low expression in colon cancer. For two of these, miR-15 and miR-16, the coding regions are epigenetically silenced in cancer due to histone deacetylase activity.[165] When these microRNAs are expressed at a low level, then HMGA1 and HMGA2 proteins are expressed at a high level. HMGA1 and HMGA2 target (reduce expression of) BRCA1 and ERCC1 DNA repair [166] genes. Thus DNA repair can be reduced, likely contributing to cancer progression.[149]

In contrast to the previous example, where under-expression of miRNAs indirectly caused reduced expression of DNA repair genes, in some cases over-expression of certain miRNAs may directly reduce expression of specific DNA repair proteins. Wan et al.[167] referred to 6 DNA repair genes that are directly targeted by the miRNAs indicated: ATM (miR-421), RAD52 (miR-210, miR-373), RAD23B (miR-373), MSH2 (miR-21), BRCA1 (miR-182) and P53 (miR-504, miR-125b). More recently, Tessitore et al.[168] listed multiple DNA repair genes directly targeted by these additional miRNAs: ATM (miR-100, miR18a, miR-101), DNA-PK (miR-101), ATR (mir-185), Wip1 (miR-16), MLH1, MSH2, MSH6 (miR-155), ERCC3, ERCC4 (miR-192) and UNG2 (miR-16, miR-34c). Among these miRNAs, miR-16, miR-18a, miR-21, miR-34c, miR-101, miR-125b, miR-155, miR-182, miR-185, miR-192 and miR-373 were identified by Schnekenburger and Diederich[164] as over-expressed in colon cancer through epigenetic hypomethylation. Over expression of any one of these miRNAs can cause reduced expression of its target DNA repair gene.

miRNA and heart disease[edit]

The global role of miRNA function in the heart has been addressed by conditionally inhibiting miRNA maturation in the murine heart, and has revealed that miRNAs play an essential role during its development.[169][170] miRNA expression profiling studies demonstrate that expression levels of specific miRNAs change in diseased human hearts, pointing to their involvement in cardiomyopathies.[171][172][173] Furthermore, studies on specific miRNAs in animal models have identified distinct roles for miRNAs both during heart development and under pathological conditions, including the regulation of key factors important for cardiogenesis, the hypertrophic growth response, and cardiac conductance.[170][174][175][176][177][178]


Murine microRNA-712 is a potential biomarker (i.e. predictor) for atherosclerosis, a cardiovascular disease of the arterial wall associated with lipid retention and inflammation.[179] Non-laminar blood flow also correlates with development of atherosclerosis as mechanosenors of epithelial cells respond to the sheer force of disturbed flow (d-flow).[166] A number of pro-atherogenic genes including matrix metalloproteinases (MMPs) are upregulated by d-flow ,[166] mediating pro-inflammatory and pro-angiogenic signals. These findings were observed in ligated carotid arteries of mice to mimic the effects of d-flow. Within 24 hours, pre-existing immature miR-712 formed mature miR-712 suggesting that miR-712 is flow-sensitive.[166] Coinciding with these results, miR-712 is also upregulated in endothelial cells exposed to naturally occurring d-flow in the greater curvature of the aortic arch.[166]

Gene Origin

Pre-mRNA sequence of miR-712 is generated from the murine ribosomal RN45s gene at the internal transcribed spacer region 2 (ITS2).[166] XRN1 is an exonuclease that degrades the ITS2 region during processing of RN45s .[166] Reduction of XRN1 under d-flow conditions therefore leads to the accumulation of miR-712.[166]


MiR-712 targets tissue inhibitor of metalloproteinases 3 (TIMP3).[166] TIMPs normally regulate activity of matrix metalloproteinases (MMPs) which degrade the extracellular matrix (ECM). Arterial ECM is mainly composed of collagen and elastin fibers, providing the structural support and recoil properties of arteries.[180] These fibers play a critical role in regulation of vascular inflammation and permeability, which are important in the development of atherosclerosis.[181] Expressed by endothelial cells, TIMP3 is the only ECM bound TIMP.[180] A decrease in TIMP3 expression results in an increase of ECM degradation in the presence of d-flow. Consistent with these findings, inhibition of pre-miR712 increases expression of TIMP3 in cells, even when exposed to turbulent flow.[166]

TIMP3 also decreases the expression of TNFα (a pro-inflammatory regulator) during turbulent flow.[166]  Activity of TNFα in turbulent flow was measured by the expression of TNFα converting enzyme (TACE) in blood. TNFα decreased if miR-712 was inhibited or TIMP3 overexpressed,[166] suggesting that miR-712 and TIMP3 regulate TACE activity in turbulent flow conditions.

Anti-miR-712 effectively suppresses d-flow induced miR-712 expression and increases TIMP3 expression.[166] Anti-miR-712 also inhibits vascular hyperpermeability, thereby significantly reducing atherosclerosis lesion development and immune cell infiltration.[166]

Human Homolog microRNA-205

The human homolog of miR-712 was found on the RN45s homolog gene, which maintains similar miRNAs to mice.[166] MiR-205 of humans share similar sequences with miR-712 of mice and is conserved across most vertebrates.[166] MiR-205 and miR-712 also share more than 50% of the cell signaling targets, including TIMP3.[166]

When tested, d-flow decreased the expression of XRN1 in humans as it did in mice endothelial cells, indicating that there may be a common role of XRN1 in human.[166] While the human homolog has not been thoroughly studied, the discovery and function of miRNA-712 can give weight for future research on its potential as a biomarker in mice models of atherosclerosis.

miRNA and the nervous system[edit]

miRNAs appear to regulate the nervous system.[182] Neural miRNAs are involved at various stages of synaptic development, including dendritogenesis (involving miR-132, miR-134 and miR-124), synapse formation and synapse maturation (where miR-134 and miR-138 are thought to be involved).[183] Some studies find altered miRNA expression in schizophrenia.[184][185]

miRNA and obesity[edit]

miRNAs play crucial roles in the regulation of stem cell progenitors differentiating into adipocytes.[186] Studies to determine what role pluripotent stem cells play in adipogenesis, were examined in the immortalized human bone marrow-derived stromal cell line hMSC-Tert20.[187] Decreased expression of miR-155,miR-221,and miR-222, have been found during the adipogenic programming of both immortalized and primary hMSCs, suggesting that they act as negative regulators of differentiation. Conversely, ectopic expression of the miRNAs 155,221, and 222 significantly inhibited adipogenesis and repressed induction of the master regulators PPARγ and CCAAT/enhancer-binding protein alpha (CEBPA).[188] This paves the way for possible obesity treatments on the genetic level.

Another class of miRNAs that regulate insulin resistance, obesity, and diabetes, is the let-7 family. Let-7 is known to accumulate in human tissues during the course of aging. When let-7 was ectopically overexpressed to mimic accelerated aging, mice became insulin-resistant, and thus more prone to high fat diet-induced obesity and diabetes.[189] In contrast when let-7 was inhibited by injections of let-7-specific antagomirs, mice become more insulin-sensitive, and remarkably resistant to high fat diet-induced obesity and diabetes. Not only could let-7 inhibition prevent obesity and diabetes, it could also reverse and cure diabetes.[190] These experimental findings suggest that let-7 inhibition could represent a new therapy for obesity and type 2 diabetes.

miRNA and non-coding RNAs[edit]

When the human genome project mapped its first chromosome in 1999, it was predicted the genome would contain over 100,000 protein coding genes. However, only around 20,000 were eventually identified (International Human Genome Sequencing Consortium, 2004).[191] Since then, the advent of bioinformatics approaches combined with genome tiling studies examining the transcriptome,[192] systematic sequencing of full length cDNA libraries,[193] and experimental validation[194] (including the creation of miRNA derived antisense oligonucleotides called antagomirs) have revealed that many transcripts are non protein-coding RNA, including several snoRNAs and miRNAs.[195]

miRNA and viruses[edit]

The expression of transcription activators by human herpesvirus-6 DNA is believed to be regulated by viral miRNA.[196]

miRNA target prediction[edit]

miRNAs can bind to target messenger RNA (mRNA) transcripts of protein-coding genes and negatively control their translation or cause mRNA degradation. It is of key importance to identify the miRNA targets accurately. A detailed review for the advances in the miRNA target identification methods and available resources has been published by Zheng et al.[197]

See also[edit]


  1. ^ Chen, Kevin; Rajewsky, Nikolaus (2007). "The evolution of gene regulation by transcription factors and microRNAs". Nature Reviews Genetics 8 (2): 93–103. doi:10.1038/nrg1990. PMID 17230196. 
  2. ^ a b c d Bartel DP (January 2009). "MicroRNAs: target recognition and regulatory functions". Cell 136 (2): 215–33. doi:10.1016/j.cell.2009.01.002. PMC 3794896. PMID 19167326. 
  3. ^ Fabian, MR; Sonenberg, N; Filipowicz, W (2010). "Regulation of mRNA translation and stability by microRNAs.". Annual review of biochemistry 79: 351–79. PMID 20533884. 
  4. ^ Homo sapiens miRNAs in the miRBase at Manchester University
  5. ^ Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z (July 2005). "Identification of hundreds of conserved and nonconserved human microRNAs". Nat. Genet. 37 (7): 766–70. doi:10.1038/ng1590. PMID 15965474. 
  6. ^ Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB, Bartel DP (April 2003). "The microRNAs of Caenorhabditis elegans". Genes Dev. 17 (8): 991–1008. doi:10.1101/gad.1074403. PMC 196042. PMID 12672692. 
  7. ^ a b Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T (April 2002). "Identification of tissue-specific microRNAs from mouse". Curr. Biol. 12 (9): 735–9. doi:10.1016/S0960-9822(02)00809-6. PMID 12007417. 
  8. ^ a b c Lewis BP, Burge CB, Bartel DP (2005). "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets". Cell 120 (1): 15–20. doi:10.1016/j.cell.2004.12.035. PMID 15652477. 
  9. ^ a b Friedman RC, Farh KK, Burge CB, Bartel DP (January 2009). "Most mammalian mRNAs are conserved targets of microRNAs". Genome Res. 19 (1): 92–105. doi:10.1101/gr.082701.108. PMC 2612969. PMID 18955434. 
  10. ^ Axtell, MJ; Bartel, DP (2005 Jun). "Antiquity of microRNAs and their targets in land plants.". The Plant cell 17 (6): 1658–73. PMID 15849273. 
  11. ^ Tanzer A, Stadler PF (May 2004). "Molecular evolution of a microRNA cluster". J. Mol. Biol. 339 (2): 327–35. doi:10.1016/j.jmb.2004.03.065. PMID 15136036. 
  12. ^ Lee CT, Risom T, Strauss WM (April 2007). "Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny". DNA Cell Biol. 26 (4): 209–18. doi:10.1089/dna.2006.0545. PMID 17465887. 
  13. ^ Peterson, KJ; Dietrich, MR; McPeek, MA (2009 Jul). "MicroRNAs and metazoan macroevolution: insights into canalization, complexity, and the Cambrian explosion.". BioEssays : news and reviews in molecular, cellular and developmental biology 31 (7): 736–47. PMID 19472371. 
  14. ^ Shabalina SA, Koonin EV (October 2008). "Origins and evolution of eukaryotic RNA interference". Trends in Ecology and Evolution. 10 (10): 578–587. doi:10.1016/j.tree.2008.06.005. PMC 2695246. PMID 18715673. 
  15. ^ Axtell, MJ; Westholm, JO; Lai, EC (2011). "Vive la différence: biogenesis and evolution of microRNAs in plants and animals.". Genome biology 12 (4): 221. PMID 21554756. 
  16. ^ Jones-Rhoades, MW; Bartel, DP; Bartel, B (2006). "MicroRNAS and their regulatory roles in plants.". Annual review of plant biology 57: 19–53. PMID 16669754. 
  17. ^ a b c Lewis BP, Shih IH, Jones-Rhoades M, Bartel DP, Burge CB (2003). "Prediction of Mammalian MicroRNA Targets". Cell 115 (7): 787–798. doi:10.1016/S0092-8674(03)01018-3. PMID 14697198. 
  18. ^ Rajewsky, Nikolaus. "microRNA target predictions in animals". Nature Genetics 38 (6s): S8–S13. doi:10.1038/ng1798. 
  19. ^ Krek, Azra; Grün, Dominic; Poy, Matthew N; Wolf, Rachel; Rosenberg, Lauren; Epstein, Eric J; MacMenamin, Philip; da Piedade, Isabelle; Gunsalus, Kristin C; Stoffel, Markus; Rajewsky, Nikolaus. "Combinatorial microRNA target predictions". Nature Genetics 37 (5): 495–500. doi:10.1038/ng1536. PMID 15806104. 
  20. ^ a b Lee RC, Feinbaum RL, Ambros V (December 1993). "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14". Cell 75 (5): 843–54. doi:10.1016/0092-8674(93)90529-Y. PMID 8252621. 
  21. ^ a b Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G (February 2000). "The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans". Nature 403 (6772): 901–6. Bibcode:2000Natur.403..901R. doi:10.1038/35002607. PMID 10706289. 
  22. ^ a b Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (November 2000). "Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA". Nature 408 (6808): 86–9. doi:10.1038/35040556. PMID 11081512. 
  23. ^ a b Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (October 2001). "Identification of novel genes coding for small expressed RNAs". Science 294 (5543): 853–8. Bibcode:2001Sci...294..853L. doi:10.1126/science.1064921. PMID 11679670. 
  24. ^ a b c Lau NC, Lim LP, Weinstein EG, Bartel DP (October 2001). "An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans". Science 294 (5543): 858–62. Bibcode:2001Sci...294..858L. doi:10.1126/science.1065062. PMID 11679671. 
  25. ^ a b Lee RC, Ambros V (October 2001). "An extensive class of small RNAs in Caenorhabditis elegans". Science 294 (5543): 862–4. Bibcode:2001Sci...294..862L. doi:10.1126/science.1065329. PMID 11679672. 
  26. ^ Jones-Rhoades, MW; Bartel, DP; Bartel, B (2006). "MicroRNAS and their regulatory roles in plants.". Annual review of plant biology 57: 19–53. PMID 16669754. 
  27. ^ Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM (April 2003). "bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila". Cell 113 (1): 25–36. doi:10.1016/S0092-8674(03)00231-9. PMID 12679032. 
  28. ^ Cuellar TL, McManus MT (December 2005). "MicroRNAs and endocrine biology". J. Endocrinol. 187 (3): 327–32. doi:10.1677/joe.1.06426. PMID 16423811. 
  29. ^ Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M (November 2004). "A pancreatic islet-specific microRNA regulates insulin secretion". Nature 432 (7014): 226–30. Bibcode:2004Natur.432..226P. doi:10.1038/nature03076. PMID 15538371. 
  30. ^ Chen CZ, Li L, Lodish HF, Bartel DP (January 2004). "MicroRNAs modulate hematopoietic lineage differentiation". Science 303 (5654): 83–6. Bibcode:2004Sci...303...83C. doi:10.1126/science.1091903. PMID 14657504. 
  31. ^ Wilfred BR, Wang WX, Nelson PT (July 2007). "Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways". Mol. Genet. Metab. 91 (3): 209–17. doi:10.1016/j.ymgme.2007.03.011. PMC 1978064. PMID 17521938. 
  32. ^ Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ (August 2005). "The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb". Proc. Natl. Acad. Sci. U.S.A. 102 (31): 10898–903. Bibcode:2005PNAS..10210898H. doi:10.1073/pnas.0504834102. PMC 1182454. PMID 16040801. 
  33. ^ Trang P, Weidhaas JB, Slack FJ (December 2008). "MicroRNAs as potential cancer therapeutics". Oncogene. 27 Suppl 2: S52–7. doi:10.1038/onc.2009.353. PMID 19956180. 
  34. ^ Li C, Feng Y, Coukos G, Zhang L (December 2009). "Therapeutic microRNA strategies in human cancer". AAPS J 11 (4): 747–57. doi:10.1208/s12248-009-9145-9. PMC 2782079. PMID 19876744. 
  35. ^ Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F (January 2010). "microRNA: emerging therapeutic targets in acute ischemic diseases". Pharmacol. Ther. 125 (1): 92–104. doi:10.1016/j.pharmthera.2009.10.003. PMID 19896977. 
  36. ^ Hydbring, Per; Badalian-Very, Gayane (August 2013). "Clinical applications of microRNAs". F1000Research 2. doi:10.12688/f1000research.2-136.v2. 
  37. ^ Thomson DW, Bracken CP, Goodall GJ (September 2011). "Experimental strategies for microRNA target identification". Nucleic Acids Res. 39 (16): 6845–53. doi:10.1093/nar/gkr330. PMC 3167600. PMID 21652644. 
  38. ^ John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (November 2004). "Human MicroRNA targets". PLoS Biol. 2 (11): e363. doi:10.1371/journal.pbio.0020363. PMC 521178. PMID 15502875. 
  39. ^ Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (May 2005). "Combinatorial microRNA target predictions". Nat. Genet. 37 (5): 495–500. doi:10.1038/ng1536. PMID 15806104. 
  40. ^ Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (September 2008). "Widespread changes in protein synthesis induced by microRNAs". Nature 455 (7209): 58–63. doi:10.1038/nature07228. PMID 18668040. 
  41. ^ Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP (September 2008). "The impact of microRNAs on protein output". Nature 455 (7209): 64–71. doi:10.1038/nature07242. PMC 2745094. PMID 18668037. 
  42. ^ Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, Matzke M, Ruvkun G, Tuschl T (March 2003). "A uniform system for microRNA annotation". RNA 9 (3): 277–9. doi:10.1261/rna.2183803. PMC 1370393. PMID 12592000. 
  43. ^ Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (January 2006). "miRBase: microRNA sequences, targets and gene nomenclature". Nucleic Acids Res. 34 (Database issue): D140–4. doi:10.1093/nar/gkj112. PMC 1347474. PMID 16381832. 
  44. ^ Wright, MW; Bruford, EA (Jan 2011). "Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature.". Human genomics 5 (2): 90–8. PMID 21296742. 
  45. ^ Bartel, DP (Jan 23, 2004). "MicroRNAs: genomics, biogenesis, mechanism, and function.". Cell 116 (2): 281–97. doi:10.1016/S0092-8674(04)00045-5. PMID 14744438. 
  46. ^ a b c d e f Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN (October 2004). "MicroRNA genes are transcribed by RNA polymerase II". EMBO J. 23 (20): 4051–60. doi:10.1038/sj.emboj.7600385. PMC 524334. PMID 15372072. 
  47. ^ Mraz M, Dolezalova D, Plevova K, Stano Kozubik K, Mayerova V, Cerna K, Musilova K, Tichy B, Pavlova S, Borsky M, Verner J, Doubek M, Brychtova Y, Trbusek M, Hampl A, Mayer J, Pospisilova S (March 2012). "MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia". Blood 119 (9): 2110–3. doi:10.1182/blood-2011-11-394874. PMID 22234685. 
  48. ^ a b Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (October 2004). "Identification of mammalian microRNA host genes and transcription units". Genome Res. 14 (10A): 1902–10. doi:10.1101/gr.2722704. PMC 524413. PMID 15364901. 
  49. ^ a b c d Cai X, Hagedorn CH, Cullen BR (December 2004). "Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs". RNA 10 (12): 1957–66. doi:10.1261/rna.7135204. PMC 1370684. PMID 15525708. 
  50. ^ Weber MJ (January 2005). "New human and mouse microRNA genes found by homology search". FEBS J. 272 (1): 59–73. doi:10.1111/j.1432-1033.2004.04389.x. PMID 15634332. 
  51. ^ Kim YK, Kim VN (February 2007). "Processing of intronic microRNAs". EMBO J. 26 (3): 775–83. doi:10.1038/sj.emboj.7601512. PMC 1794378. PMID 17255951. 
  52. ^ Baskerville S, Bartel DP (March 2005). "Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes". RNA 11 (3): 241–7. doi:10.1261/rna.7240905. PMC 1370713. PMID 15701730. 
  53. ^ Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H (2005). "Clustering and conservation patterns of human microRNAs". Nucleic Acids Res. 33 (8): 2697–706. doi:10.1093/nar/gki567. PMC 1110742. PMID 15891114. 
  54. ^ a b Zhou X, Ruan J, Wang G, Zhang W (March 2007). "Characterization and identification of microRNA core promoters in four model species". PLoS Comput. Biol. 3 (3): e37. Bibcode:2007PLSCB...3...37Z. doi:10.1371/journal.pcbi.0030037. PMC 1817659. PMID 17352530. 
  55. ^ Faller M, Guo F (November 2008). "MicroRNA biogenesis: there's more than one way to skin a cat". Biochim. Biophys. Acta 1779 (11): 663–7. doi:10.1016/j.bbagrm.2008.08.005. PMC 2633599. PMID 18778799. 
  56. ^ Gregory RI, Chendrimada TP, Shiekhattar R (2006). "MicroRNA biogenesis: isolation and characterization of the microprocessor complex". Methods Mol. Biol. 342: 33–47. doi:10.1385/1-59745-123-1:33. ISBN 1-59745-123-1. PMID 16957365. 
  57. ^ Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC (October 2007). "Mammalian mirtron genes". Mol. Cell 28 (2): 328–36. doi:10.1016/j.molcel.2007.09.028. PMC 2763384. PMID 17964270. 
  58. ^ a b Kawahara Y, Megraw M, Kreider E, Iizasa H, Valente L, Hatzigeorgiou AG, Nishikura K (September 2008). "Frequency and fate of microRNA editing in human brain". Nucleic Acids Res. 36 (16): 5270–80. doi:10.1093/nar/gkn479. PMC 2532740. PMID 18684997. 
  59. ^ Winter J, Jung S, Keller S, Gregory RI, Diederichs S (March 2009). "Many roads to maturity: microRNA biogenesis pathways and their regulation". Nat. Cell Biol. 11 (3): 228–34. doi:10.1038/ncb0309-228. PMID 19255566. 
  60. ^ Ohman M (October 2007). "A-to-I editing challenger or ally to the microRNA process". Biochimie 89 (10): 1171–6. doi:10.1016/j.biochi.2007.06.002. PMID 17628290. 
  61. ^ a b Murchison EP, Hannon GJ (June 2004). "miRNAs on the move: miRNA biogenesis and the RNAi machinery". Curr. Opin. Cell Biol. 16 (3): 223–9. doi:10.1016/j.ceb.2004.04.003. PMID 15145345. 
  62. ^ a b c Lund E, Dahlberg JE (2006). "Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs". Cold Spring Harb. Symp. Quant. Biol. 71: 59–66. doi:10.1101/sqb.2006.71.050. PMID 17381281. 
  63. ^ Ji X (2008). "The mechanism of RNase III action: how dicer dices". Curr. Top. Microbiol. Immunol. Current Topics in Microbiology and Immunology 320: 99–116. doi:10.1007/978-3-540-75157-1_5. ISBN 978-3-540-75156-4. PMID 18268841. 
  64. ^ Lelandais-Brière C, Sorin C, Declerck M, Benslimane A, Crespi M, Hartmann C (March 2010). "Small RNA diversity in plants and its impact in development". Current Genomics 11 (1): 14–23. doi:10.2174/138920210790217918. PMC 2851111. PMID 20808519. 
  65. ^ Rana TM (January 2007). "Illuminating the silence: understanding the structure and function of small RNAs". Nat. Rev. Mol. Cell Biol. 8 (1): 23–36. doi:10.1038/nrm2085. PMID 17183358. 
  66. ^ a b Schwarz DS, Zamore PD (May 2002). "Why do miRNAs live in the miRNP?". Genes Dev. 16 (9): 1025–31. doi:10.1101/gad.992502. PMID 12000786. 
  67. ^ Krol J, Sobczak K, Wilczynska U, Drath M, Jasinska A, Kaczynska D, Krzyzosiak WJ (2004). "Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA/short hairpin RNA design". J Biol Chem 279 (40): 42230–9. doi:10.1074/jbc.M404931200. PMID 15292246. 
  68. ^ Khvorova A, Reynolds A, Jayasena SD (2003). "Functional siRNAs and miRNAs exhibit strand bias". Cell 115 (2): 209–16. doi:10.1016/S0092-8674(03)00801-8. PMID 14567918. 
  69. ^ Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N, Zamore PD (2003). "Asymmetry in the assembly of the RNAi enzyme complex". Cell 115 (2): 199–208. doi:10.1016/S0092-8674(03)00759-1. PMID 14567917. 
  70. ^ Lin SL, Chang D, Ying SY (2005). "Asymmetry of intronic pre-miRNA structures in functional RISC assembly". Gene 356: 32–8. doi:10.1016/j.gene.2005.04.036. PMC 1788082. PMID 16005165. 
  71. ^ Okamura K, Chung WJ, Lai EC (2008). "The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs". Cell Cycle 7 (18): 2840–5. doi:10.4161/cc.7.18.6734. PMC 2697033. PMID 18769156. 
  72. ^ a b Pratt AJ, MacRae IJ (July 2009). "The RNA-induced silencing complex: a versatile gene-silencing machine". J. Biol. Chem. 284 (27): 17897–901. doi:10.1074/jbc.R900012200. PMC 2709356. PMID 19342379. 
  73. ^ MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA (January 2008). "In vitro reconstitution of the human RISC-loading complex". Proc. Natl. Acad. Sci. U.S.A. 105 (2): 512–7. Bibcode:2008PNAS..105..512M. doi:10.1073/pnas.0710869105. PMC 2206567. PMID 18178619. 
  74. ^ Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, Rappsilber J, Mann M, Dreyfuss G (March 2002). "miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs". Genes Dev. 16 (6): 720–8. doi:10.1101/gad.974702. PMC 155365. PMID 11914277. 
  75. ^ Meister G, Landthaler M, Peters L, Chen P, Urlaub H, Lurhmann R, Tuschl T (December 2005). "Identification of Novel Argonaute-Associated Proteins". Current Biology 15 (23): 2149–55. doi:10.1016/j.cub.2005.10.048. PMID 16289642. 
  76. ^ Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (February 2005). "Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs". Nature 433 (7027): 769–73. Bibcode:2005Natur.433..769L. doi:10.1038/nature03315. PMID 15685193. 
  77. ^ a b c Kai ZS, Pasquinelli AE (January 2010). "MicroRNA assassins: factors that regulate the disappearance of miRNAs". Nat. Struct. Mol. Biol. 17 (1): 5–10. doi:10.1038/nsmb.1762. PMID 20051982. 
  78. ^ Chatterjee S, Großhans H (September 2009). "Active turnover modulates mature microRNA activity in Caenorhabditis elegans". Nature 461 (7263): 546–459. Bibcode:2009Natur.461..546C. doi:10.1038/nature08349. PMID 19734881. 
  79. ^ a b c Morozova N, Zinovyev A, Nonne N, Pritchard LL, Gorban AN, Harel-Bellan A (September 2012). "Kinetic signatures of microRNA modes of action". RNA 18 (9): 1635–55. doi:10.1261/rna.032284.112. PMC 3425779. PMID 22850425. 
  80. ^ Wang XJ, Reyes JL, Chua NH, Gaasterland T (2004). "Prediction and identification of Arabidopsis thaliana microRNAs and their mRNA targets". Genome Biol. 5 (9): R65. doi:10.1186/gb-2004-5-9-r65. PMC 522872. PMID 15345049. 
  81. ^ Kawasaki H, Taira K (2004). "MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells". Nucleic Acids Symp Ser 48 (48): 211–2. doi:10.1093/nass/48.1.211. PMID 17150553. 
  82. ^ a b Moxon S, Jing R, Szittya G, Schwach F, Rusholme Pilcher RL, Moulton V, Dalmay T (October 2008). "Deep sequencing of tomato short RNAs identifies microRNAs targeting genes involved in fruit ripening". Genome Res. 18 (10): 1602–9. doi:10.1101/gr.080127.108. PMC 2556272. PMID 18653800. 
  83. ^ Script error
  84. ^ Script error
  85. ^ Script error
  86. ^ Script error
  87. ^ Script error
  88. ^ Script error
  89. ^ Script error
  90. ^ Script error
  91. ^ Script error
  92. ^ Script error
  93. ^ Script error
  94. ^ a b Script error
  95. ^ Script error
  96. ^ a b Script error
  97. ^ a b c Script error
  98. ^ a b c Script error
  99. ^ Script error
  100. ^ Script error
  101. ^ Script error
  102. ^ Script error
  103. ^ Script error
  104. ^ Script error
  105. ^ Script error
  106. ^ Script error
  107. ^ Script error
  108. ^ Script error
  109. ^ Script error
  110. ^ Script error
  111. ^ Script error
  112. ^ Script error
  113. ^ Script error
  114. ^ Script error
  115. ^ Script error
  116. ^ Script error
  117. ^ Script error
  118. ^ Script error
  119. ^ Script error
  120. ^ Script error
  121. ^ Script error
  122. ^ Script error
  123. ^ Script error
  124. ^ Script error
  125. ^ Script error
  126. ^ Script error
  127. ^ Script error
  128. ^ a b c Script error edit
  129. ^ Script error
  130. ^ Script error
  131. ^ Script error
  132. ^ Script error
  133. ^ a b Script error
  134. ^ a b Script error
  135. ^ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538124/
  136. ^ Script error
  137. ^ Script error
  138. ^ Script error
  139. ^ Script error
  140. ^ Script error
  141. ^ Script error
  142. ^ Script error
  143. ^ Script error
  144. ^ Script error
  145. ^ MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. Guangxian Xu et al, 2013
  146. ^ Script error
  147. ^ Script error
  148. ^ Script error
  149. ^ a b Script error
  150. ^ O'Hagan HM, Mohammad HP, Baylin SB. (2008) Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island" PLoS Genet 4(8) e1000155. doi:10.1371/journal.pgen.1000155 PMID 18704159
  151. ^ Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (2007). DNA damage, homology-directed repair, and DNA methylation" PLoS Genet 3(7) e110. doi:10.1371/journal.pgen.0030110 PMID 17616978
  152. ^ Jasperson KW, Tuohy TM, Neklason DW, Burt RW (2010). Hereditary and familial colon cancer" Gastroenterology 138(6) 2044-2058. doi: 10.1053/j.gastro.2010.01.054. PMID 20420945
  153. ^ Script error
  154. ^ Script error
  155. ^ a b c Script error
  156. ^ Script error
  157. ^ Script error
  158. ^ Script error
  159. ^ Script error
  160. ^ Script error
  161. ^ Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM, Stern S, Oatman N, Banerjee B, Bernstein C. (2012). Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr 3(1) 3. doi: 10.1186/2041-9414-3-3. PMID 22494821 http://www.ncbi.nlm.nih.gov/pubmed/22494821
  162. ^ Script error
  163. ^ Script error
  164. ^ a b Script error
  165. ^ Script error
  166. ^ a b c d e f g h i j k l m n o p q r Son D.j., Kumar S., Takabe W., Kim C.W., Ni C.W., Alberts-Grill N., Jang I.H., Kim S., Kim W., Kang S.W., Baker A.H., Seo J.W., Ferrara K.W., and Jo H. (2013). The atypical mechnosenstitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nature Communications. 4:3000. 
  167. ^ Script error
  168. ^ Script error
  169. ^ Script error
  170. ^ a b Script error
  171. ^ Script error
  172. ^ Script error
  173. ^ Script error
  174. ^ Script error
  175. ^ Script error
  176. ^ Script error
  177. ^ Script error
  178. ^ Script error
  179. ^ Insull W. (2009). The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment. The American Journal of Medicine. 122: S3-S14. 
  180. ^ a b Basu R., Fan D., Kandalam V., Lee J., Das S.S., Wang X., Baldwin T.A., Oudit G.Y., and Kassiri Z. (2012). Timp3 Gene Leads to Abdominal Aortic Aneurysm Formation in Response to Angiotensin II. The Journal of Biological Chemistry. 287: 44083-44096.
  181. ^ Libby P. (2002). Inflammation in atherosclerosis. Nature. 402:868-874.
  182. ^ Script error
  183. ^ Script error
  184. ^ Script error
  185. ^ Script error
  186. ^ Script error
  187. ^ Script error
  188. ^ Script error
  189. ^ Script error
  190. ^ Script error
  191. ^ Script error
  192. ^ Script error
  193. ^ Script error
  194. ^ Script error
  195. ^ Script error
  196. ^ Script error
  197. ^ Script error


  • miRNA definition and classification: Script error
  • Science review of small RNA: Script error
  • Discovery of lin-4, the first miRNA to be discovered: Script error

External links[edit]

Script error

  • The miRBase database
  • The miRNA Blog
  • miR2Disease, a manually curated database documenting known relationships between miRNA dysregulation and human disease.
  • semirna, Web application to search for microRNAs in a plant genome.
  • miRandola: Extracellular Circulating microRNAs Database.
  • MirOB: MicroRNA targets database and data analysis and dataviz tool.

Script error Script error Script error

Script error